Digital pills: a scoping review of the empirical literature and analysis of the ethical aspects

BackgroundDigital Pills (DP) are an innovative drug-device technology that permits to combine traditional medications with a monitoring system that automatically records data about medication adherence as well as patients’ physiological data. Although DP are a promising innovation in the field of digital medicine, their use has also raised a number of ethical concerns. These ethical concerns, however, have been expressed principally from a theoretical perspective, whereas an ethical analysis with a more empirically oriented approach is lacking. There is also a lack of clarity about the empirical evidence available concerning the application of this innovative digital medicine.MethodsTo map the studies where DP have been tested on patients and discuss the ethically relevant issues evident therein, we performed a scoping review of the empirical literature concerning DP.ResultsOur search allowed us to identify 18 papers reporting on studies where DP were tested on patients. These included studies with different designs and involving patients with a variety of conditions. In the empirical literature, a number of issues with ethical relevance were evident. At the patient level, the ethical issues include users’ interaction with DP, personal sphere, health-related risks and patients’ benefits. At the provider level, ethically relevant issues touch upon the doctor-patient relationship and the question of data access. At the societal level, they concern the benefits to society, the quality of evidence and the dichotomy device-medicine.ConclusionsWe conclude that evidence concerning DP is not robust and that more research should be performed and study results made available to evaluate this digital medicine. Moreover, our analysis of the ethically relevant aspects within empirical literature underscores that there are concrete and specific open questions that should be tackled in the ethical discussion about this new technological solution.

[1]  A. L. Dal-Fabbro,et al.  Adherence to long term therapies: evidence for action , 2005 .

[2]  Digital medicines: clinical review on the safety of tablets with sensors , 2018, Expert opinion on drug safety.

[3]  Vilhjalmur Arnason,et al.  Coding and Consent: Moral Challenges of the Database Project in Iceland , 2004, Bioethics.

[4]  H. Krumholz Big data and new knowledge in medicine: the thinking, training, and tools needed for a learning health system. , 2014, Health affairs.

[5]  L. DiCarlo,et al.  Medication adherence and activity patterns underlying uncontrolled hypertension: Assessment and recommendations by practicing pharmacists using digital health care. , 2016, Journal of the American Pharmacists Association : JAPhA.

[6]  What is digital medicine , 2002 .

[7]  M. Zdeblick,et al.  A Digital Health Solution for Using and Managing Medications: Wirelessly Observed Therapy , 2012, IEEE Pulse.

[8]  Chad Darling,et al.  Utilizing an Ingestible Biosensor to Assess Real-Time Medication Adherence , 2015, Journal of Medical Toxicology.

[9]  Larry Schlosser Labeling , 1984, Computer Vision, A Reference Guide.

[10]  M. Frigerio Getting approval for new therapeutic medical devices versus drugs: are the differences justified? , 2016, European Respiratory Review.

[11]  Katie Atkinson,et al.  Human factors evaluation of a novel digital medicine system in psychiatry , 2018, Neuropsychiatric disease and treatment.

[12]  B. Hofmann,et al.  Tackling ethical issues in health technology assessment: A proposed framework , 2011, International Journal of Technology Assessment in Health Care.

[13]  J. McGowan,et al.  PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.

[14]  R. Reves,et al.  Feasibility of an Ingestible Sensor-Based System for Monitoring Adherence to Tuberculosis Therapy , 2013, PloS one.

[15]  R. Haubrich,et al.  Digitizing Medicines for Remote Capture of Oral Medication Adherence Using Co‐encapsulation , 2017, Clinical pharmacology and therapeutics.

[16]  A. Carter,et al.  Surveillance Medicine in the DigitalEra: Lessons From Addiction Treatment , 2018, The American journal of bioethics : AJOB.

[17]  Lisa Rosenbaum Swallowing a Spy - The Potential Uses of Digital Adherence Monitoring. , 2018, The New England journal of medicine.

[18]  A. Garber Modernizing device regulation. , 2010, The New England journal of medicine.

[19]  Eric Racine,et al.  Ethical aspects of brain computer interfaces: a scoping review , 2017, BMC medical ethics.

[20]  Yoona Kim,et al.  Efficacy and safety of a medication dose reminder feature in a digital health offering with the use of sensor-enabled medicines. , 2017, Journal of the American Pharmacists Association.

[21]  L. DiCarlo,et al.  Cost comparison of wirelessly vs. directly observed therapy for adherence confirmation in anti-tuberculosis treatment. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[22]  Qualification opinion on ingestible sensor system for medication adherence as biomarker for measuring patient adherence to medication in clinical trials , 2016 .

[23]  Roy H Perlis,et al.  First experience with a wireless system incorporating physiologic assessments and direct confirmation of digital tablet ingestions in ambulatory patients with schizophrenia or bipolar disorder. , 2013, The Journal of clinical psychiatry.

[24]  G. Ostuzzi,et al.  Can a digital medicine system improve adherence to antipsychotic treatment? , 2018, Epidemiology and Psychiatric Sciences.

[25]  T. Tomlinson Getting Off the Leash , 2018, The American journal of bioethics : AJOB.

[26]  Deborah Lupton,et al.  Critical perspectives on digital health technologies , 2014 .

[27]  J. Ioannidis Why Most Published Research Findings Are False , 2005 .

[28]  Eric Elenko,et al.  Defining digital medicine , 2015, Nature Biotechnology.

[29]  D. Thompson,et al.  Direct Adherence Measurement Using an Ingestible Sensor Compared With Self-Reporting in High-Risk Cardiovascular Disease Patients Who Knew They Were Being Measured: A Prospective Intervention , 2017, JMIR mHealth and uHealth.

[30]  Diana Naranjo,et al.  Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets , 2016, Diabetes Care.

[31]  A. Guta,et al.  Resisting the Digital Medicine Panopticon: Toward a Bioethics of the Oppressed , 2018, The American journal of bioethics : AJOB.

[32]  T. Thornton-Wells,et al.  Digital Therapeutics: An Integral Component of Digital Innovation in Drug Development , 2018, Clinical pharmacology and therapeutics.

[33]  Stephanie Carreiro,et al.  Digital Pills to Measure Opioid Ingestion Patterns in Emergency Department Patients With Acute Fracture Pain: A Pilot Study , 2017, Journal of medical Internet research.

[34]  D. Parker,et al.  Guidance for conducting systematic scoping reviews , 2015, International journal of evidence-based healthcare.

[35]  David Williamson Shaffer,et al.  Digital Medicine , 2023, Health Informatics.

[36]  P. Weiden,et al.  Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole , 2016, Neuropsychiatric disease and treatment.

[37]  L. DiCarlo,et al.  Patient‐Centered Home Care Using Digital Medicine and Telemetric Data for Hypertension: Feasibility and Acceptability of Objective Ambulatory Assessment , 2016, Journal of clinical hypertension.

[38]  Stephanie Carreiro,et al.  Oxycodone Ingestion Patterns in Acute Fracture Pain With Digital Pills , 2017, Anesthesia and analgesia.

[39]  A. Kopelowicz,et al.  A multicenter, open-label, pilot study evaluating the functionality of an integrated call center for a digital medicine system to optimize monitoring of adherence to oral aripiprazole in adult patients with serious mental illness , 2017, Neuropsychiatric disease and treatment.

[40]  Digital Medicine, Cybersecurity, and Ethics: An Uneasy Relationship , 2018, The American journal of bioethics : AJOB.

[41]  R. Redberg,et al.  Medical devices--balancing regulation and innovation. , 2011, The New England journal of medicine.

[42]  Michael Bryce,et al.  Test 5.14.4. Deposit 18 June 15:43, embargoed 18/07/2019 : Article -> Review article , 2019 .

[43]  Digital Medicine: Innovative Drug-Device Combination as New Measure of Medication Adherence , 2017, The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians.

[44]  T. Beauchamp,et al.  Principles of biomedical ethics , 1991 .

[45]  I. Glenn Cohen,et al.  The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine , 2018, The American journal of bioethics : AJOB.

[46]  Gwen Littlewort,et al.  Let Visuals Tell the Story: Medication Adherence in Patients with Type II Diabetes Captured by a Novel Ingestion Sensor Platform , 2015, JMIR mHealth and uHealth.

[47]  Katarzyna Wac,et al.  From Quantified Self to Quality of Life , 2018 .

[48]  Publisher's Note , 2018, Anaesthesia.

[49]  Praveen Raja,et al.  Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial , 2017, Journal of medical Internet research.

[50]  H. Arksey,et al.  Scoping studies: towards a methodological framework , 2005 .

[51]  D. Char,et al.  Surveillance and Digital Health , 2018, The American journal of bioethics : AJOB.

[52]  Andreas Bock,et al.  Medication Adherence Assessment: High Accuracy of the New Ingestible Sensor System in Kidney Transplants , 2013, Transplantation.

[53]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[54]  Daphne Zohar,et al.  Digital medicine's march on chronic disease , 2016, Nature Biotechnology.

[55]  I. Cohen,et al.  Ethical and legal issues of ingestible electronic sensors , 2019, Nature Electronics.

[56]  L. DiCarlo,et al.  First Use of an Ingestible Sensor to Manage Uncontrolled Blood Pressure in Primary Practice: The UK Hypertension Registry , 2017 .

[57]  M. Campbell,et al.  What is a pilot or feasibility study? A review of current practice and editorial policy , 2010, BMC medical research methodology.

[58]  I. Goold Digital tracking medication: big promise or Big Brother? , 2019, Law, Innovation and Technology.

[59]  D. Levac,et al.  Scoping studies: advancing the methodology , 2010, Implementation science : IS.

[60]  R. Reves,et al.  Early clinical experience with networked system for promoting patient self-management. , 2011, The American journal of managed care.

[61]  M. Mohammadnezhad,et al.  Prevalence and Characteristics of Intimate Partner Violence (IPV) Among Pregnant Women Seeking Antenatal Care, Solomon Islands (2016) , 2017 .

[62]  T. Peters-Strickland,et al.  Optimization of a Digital Medicine System in Psychiatry. , 2016, The Journal of clinical psychiatry.

[63]  M. Ienca,et al.  Digital Medicine and Ethics: Rooting for Evidence , 2018, The American journal of bioethics : AJOB.